Press release
Hypersensitivity Market Scope and Opportunities Analysis 2014 – 2020
Hypersensitivity reaction is the over reactive immunological response towards antigens. In some cases, body’s own cells are miss-read as foreign cells and immune response is mounted against these cells.Hypersensitivity may lead to serious injuries, lifelong disorders and even death. There are two types of hypersensitivity reactions, namely, immediate hypersensitivity reaction and delayed hypersensitivity. Immediate reaction also called as allergic reactions involve antibodies while delayed type reactions involve T lymphocytes.
Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2640
Hypersensitivity reactions can be classified in to four main types (Gell and Coomb’s classification), follows:
Type I- immediate hypersensitivity reaction involving IgE
Type II- cytotoxic hypersensitivity reaction involving IgG and IgM
Type III- immune-complex reaction involving circulation Ag-Ab (antigen-antibody) complex
Type IV- delayed hypersensitivity reactions involving T cells.
Hypersensitivity may lead to various disorders such as asthma, erythroblastosis fetalis, goodpasture's syndrome, Graves' disease, myasthenia gravis, rheumatoid arthritis, and systemic lupus erythematosus among others. Diagnosis of allergies is done using various molecular and immunoassays, which deliver quick and accurate test results. ImmunoCAP test by Thermo Fisher Scientific is one the most widely used test for allergy testing.
Advent of multiplex technology has also revolution allergy testing, in which single sample can be tested for multiple analytes. The test is cost effective and also required very small amount of sample to conduct the test.
Drug hypersensitivity is becoming a major concern, in which individuals suffer from allergy towards drugs, most common being insulin and beta lactums such as penicillin. Allergy is also a common disorder across the globe. According to World Allergy Organization, allergic rhinitis affects 10% to 30% of the global population while over 200 million individuals across the globe suffer from food allergy.
The data further details that, more than 10% of the adverse drug reactions are unpredictable drug hypersensitivity reactions. The prevalence of lupus is higher in Europe and Australia as compared to North America. In North America, the disease is more prevalent among Hispanics, Asians, and Native Americans according to Centers for Disease Control and Prevention (CDC). Due to this high prevalence across the globe, the demand for quick and effective treatment and diagnosis of hypersensitivity reactions is increasing.
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2640
As the clinical research advances, various drugs will be launched in the market offering better treatment for hypersensitivity. This will also add more products to the market and hence ensure continuous growth. Moreover as the drugs approach patent expiry, generic drugs are expected to hit the market, making treatment affordable to the developing and under developed countries; thus expanding geographical scope. The market is flooded with generic drugs for treatment of hypersensitivity reaction. Common drugs include astemizole, celiprolol, chlorpheniramine, diphenhydramine, fexofenadine, triamcinolone and various others. India being the home for generic drug manufacturers, the market is expected to boost as branded drugs lose their patents.
GSK manufactured Benlysta (belimumab) is a B lymphocyte stimulator, received FDA approval in 2011 for treatment of lupus. Ibuprofen and aspirin are widely prescribed anti-inflammatory drugs for suppressing symptoms of lupus. Immunosuppressant such as CellCept (Mycophenolate mofetil) by Roche, Neoral (Cyclosporine) by Novartis, Imuran (Azathioprine) by GSK are commonly prescribed for lupus treatment. KALBITOR (ecallantide) by Dyax Corp is prescribed for acute hereditary angioedema (HAE). Other key players in the market include Cadila Pharmaceuticals Ltd., Admac Pharma Ltd., DWD Pharmaceuticals Ltd, Panacea Biotec Ltd, Dr Reddy Laboratories Ltd, Glenmark Pharmaceuticals Ltd., Cipla Limited, Glaxo Smith Kline Pharmaceuticals, Sun Pharmaceutical Industries Ltd.
Obtain Report Details @ https://www.transparencymarketresearch.com/hypersensitivity-market.html
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hypersensitivity Market Scope and Opportunities Analysis 2014 – 2020 here
News-ID: 982450 • Views: …
More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…

Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…

Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…

Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Hypersensitivity
Hypersensitivity Pneumonitis Market Outlook 2026: Industry Share, Trends, and Fu …
"
The Hypersensitivity Pneumonitis (HP) market is experiencing notable growth, driven by a confluence of factors including increasing awareness of the disease, advancements in diagnostic techniques, and the rising prevalence of environmental triggers. This growth is further fueled by ongoing research into effective treatment modalities and the development of novel therapies. Technological advancements, particularly in imaging and molecular diagnostics, are playing a crucial role in early and accurate detection, leading to…
Cough Hypersensitivity Syndrome Market Size, Trends, Forecast And Strategies 202 …
The Business Research Company recently released a comprehensive report on the Global Cough Hypersensitivity Syndrome Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, the acute respiratory distress…
Cough Hypersensitivity Syndrome Market Segments, Analysis, Overview, Outlook Rep …
The new report published by The Business Research Company, titled Cough Hypersensitivity Syndrome Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the cough hypersensitivity syndrome market size has grown strongly in recent years. It will grow from $9.71 billion…
Cough Hypersensitivity Syndrome Market Research 2024-2033 - Outlook, Overview
The cough hypersensitivity syndrome market size has grown strongly in recent years. It will grow from $9.71 billion in 2023 to $10.36 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increased awareness, telemedicine and remote monitoring, public health initiatives, research funding.
The cough hypersensitivity syndrome market size is expected to see strong growth in the…
Exploring the Dynamics of the Cough Hypersensitivity Syndrome Treatment Market
The global market for cough hypersensitivity syndrome treatment is witnessing significant growth, driven by factors such as the rising prevalence of chronic respiratory diseases, increased smoking rates, and advancements in pharmacological approaches. This article provides an in-depth analysis of the market, including key players, growth trends, competitive landscape, market drivers, and future outlook.
Request to Sample PDF
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=74002
Market Size and Growth Trends: The cough hypersensitivity syndrome treatment market is projected to…
Cough Hypersensitivity Syndrome Treatment Market - Current Trends and Future Opp …
Transparency Market Research (TMR) has published a new report on the cough hypersensitivity syndrome treatment market for the forecast period of 2019-2027. According to the report, the global cough hypersensitivity syndrome treatment market was valued at ~US$ 7 Bn in 2018, and is projected to expand at a CAGR of 5.5% from 2019 to 2027.
Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=74002
Cough hypersensitivity syndrome encompasses various cough-related conditions arising from exposure to certain mechanical, thermal,…